COMBINATION OF EXERCISE AND GLP-1 RECEPTOR AGONIST TREATMENT REDUCES SEVERITY OF METABOLIC SYNDROME, ABDOMINAL OBESITY, AND INFLAMMATION: A RANDOMIZED CONTROLLED TRIAL